In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv.
Maurya S, Jain A, Rehman MT, Hakamy A, Bantun F, AlAjmi MF, Singh V, Zehra A, Khan F, Haque S, Mishra BN. In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv. Molecules. 2023 Feb 08; 28(4).